期刊文献+

miRNA-34c对三阴性乳腺癌细胞增殖和侵袭能力的影响 被引量:3

Effect of miRNA-34c on cell proliferation and invasion in triple-negative breast cancer cells
原文传递
导出
摘要 目的探讨miR-34c对三阴性乳腺癌细胞增殖、侵袭的影响及可能的分子机制。方法利用化学合成的miR-34c mimics转染三阴性乳腺癌MDA-MB-231细胞,通过MTS实验、Transwell迁移实验观察过表达miR-34c后细胞增值及侵袭能力的变化;采用流式细胞术检测过表达miR-34c对细胞周期的影响;采用Western blot检测b-catenin及其下游靶蛋白的表达情况。结果 miR-34c过表达明显抑制MDA-MB-231细胞的增殖和侵袭。过表达miR-34c诱导细胞G1期阻滞。Western blot结果显示,过表达miR-34c的MDA-MB-231细胞b-catenin及其下游靶蛋白Cyclin D1、Snail、MMP2和MMP7的表达明显下调。过表达b-catenin则逆转miR-34c对MDA-MB-231细胞的增殖和侵袭的抑制作用。结论 miR-34c可能通过抑制b-catenin信号而抑制三阴性乳腺癌MDA-MB-231细胞增殖、侵袭。 Objective To determine the effect of miR-34c on the proliferation and invasion in human triple-negative breast cancer cell line and investigate the possible molecular mechanism. Methods MiR-34c mimics was synthesized and then transfected into the cells. Cell proliferation and invasion were examined by MTS assay and Transwell chamber assay,respectively. Cell cycle distribution was detected by flow cytometry. Western blotting was used to detect the expression of b-catenin and its downstream targets. Results Over-expression of miR-34c significantly suppressed the proliferation and invasion in the MDA-MB-231 cells,arrested the cells at G1-phase. Meantime,Western blotting showed that miR-34c obviously decreased the expression of b-catenin,and its targeting proteins,cyclin D1,Snail,MMP2 and MMP7 in the MDA-MB-231 cells. In contrast,over-expression of b-catenin reversed the inhibited proliferation and invasion in the cells induced by miR-34c. Conclusion MiR-34c suppresses cell proliferation and invasion in triple-negative breast cancer MDA-MB-231 cells,probably through suppressing b-catenin signaling.
出处 《中国热带医学》 CAS 2016年第8期748-752,共5页 China Tropical Medicine
基金 国家自然科学基金(No.81201763)
关键词 三阴性乳腺癌 miRNA-34 增殖 侵袭 Triple-negative breast cancer miRNA-34 Cell proliferation Invasion
  • 相关文献

参考文献21

  • 1FAN L, STRASSER-WEIPPL K, LI J J, et al.Breast cancer in China [J]. Lancet Oncol, 2014,15(7):279-289.
  • 2BRYAN B B, SCHNITT S J, COLLINS L C. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal- like breast cancer[J]. Mod Pathol, 2006, 19(5):617-621.
  • 3袁中玉,王树森,高岩,苏争艳,罗文标,管忠震.305例三阴乳腺癌患者的临床特征及预后因素分析[J].癌症,2008,27(6):561-565. 被引量:161
  • 4GILBERT J A. Potential therapeutic target for triple-negative breast cancer [J]. Lancet Oncol, 2012,13(8):330.
  • 5GARZON R, FABBRI M,CIMMINO A, et al.MicroRNA expression and function in cancer [J]. Trends Mol Med,2006,12(12):580-587.
  • 6LIN S, GREGORY R I. MicroRNA biogenesis pathways in cancer [J]. Nat Rev Cancer, 2015,15(6):321-333.
  • 7ADAMS B D, KASINSKI A L, SLACK F J.AbezTant Regulation and Function of MicrnRNAs in Cancer [J].CurrBiol,2014,24(16):762-776.
  • 8WANG R, MA J, WU Q, et al.Functional role of miR-34 family in hu- man cancer [J].Curr Drug Targets,2013,14(10):1185-1191.
  • 9SVOBODA M, SANA J, REDOVA M,et al.MiR-34b is associated with clinical outcome in triple-negative breast cancer patients [J]. Di- agnPathol, 2012;7:31.
  • 10GYPARAKI M T, BASDRA E K, PapavassiliouAG.MicroRNAs as regulatory elements in triple negative breast cancer [J].Cancer Lett, 2014, 354(1):1-4.

二级参考文献28

  • 1Perou C M, Sorlie T, Eisen M-B, et al. Molecular portraits of human breast tumors [J]. Nature, 2000,406(6797) :747-752.
  • 2van't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer [J ]. Nature, 2002,415(6871 ) : 530-536.
  • 3Sotiriou C, Neo S Y, McShane L M, et al. Breast cancer classification and prognosis based on gene expression profiles from a population based study [J]. Proc Natl Acad Sci USA, 2003,100(18) : 10393-10398.
  • 4Rakha E A, El-Sayed M E, Green A R, et al. Prognostic markers in triple-negative breast cancer [J]. Cancer, 2007, 109( 1 ) : 25-32.
  • 5Jones C, Nonni A V, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation [ J ]. Br J Cancer, 2001,85 ( 3 ) : 422-427.
  • 6Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma [J]. Clin Cancer Res, 2004, 10 (16) :5367-5374.
  • 7Banerjee S, Reis-Filho J S, Ashley S, et al. Basal-like breast carcinomas: clinical outcome and response to chemotherapy [J]. J Clin Pathol, 2006,59(7):729-735.
  • 8Carey L A, Dees E C, Sawyer L, et al. The triple negative paradox : primary tumor chemosensitivity of breast cancer subtypes [J]. Clin Cancer Res, 2007,13(8) :2329-2334.
  • 9Chu K C, Lamar C A, Freeman H P. Racial disparities in breast carcinoma survival rates: separating factors that affect diagnosis from factors that affect treatment [J]. Cancer, 2003, 97( 11 ) : 2853-2860.
  • 10Cunningham J E, Butler W M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis [ J ]. Breast Cancer Res Treat, 2004,88 (2) : 161-176.

共引文献165

同被引文献34

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部